| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$48,437,400 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$48,437,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-12-08 |
4 |
OE |
$10.05 |
$147,303 |
D/D |
14,657 |
236,770 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2011-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
88,494 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2014-01-16 |
4 |
AS |
$64.00 |
$960,000 |
D/D |
(15,000) |
102,099 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,553 |
248,018 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-03-08 |
4 |
OE |
$10.05 |
$157,534 |
D/D |
15,675 |
144,644 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2015-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,945 |
136,044 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-04-28 |
4 |
OE |
$21.85 |
$349,600 |
D/D |
16,000 |
39,360 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-01-19 |
4 |
OE |
$16.14 |
$262,259 |
D/D |
16,249 |
162,299 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2014-02-12 |
4 |
OE |
$9.96 |
$168,075 |
D/D |
16,875 |
127,974 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2014-02-12 |
4 |
AS |
$75.00 |
$1,265,625 |
D/D |
(16,875) |
111,099 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
19,392 |
132,969 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-11-09 |
4 |
OE |
$10.05 |
$201,000 |
D/D |
20,000 |
224,571 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-12 |
4 |
OE |
$12.78 |
$255,600 |
D/D |
20,000 |
436,928 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-08-16 |
4 |
AS |
$241.33 |
$5,190,261 |
D/D |
(21,507) |
88,919 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-01-24 |
4 |
AS |
$165.00 |
$3,712,500 |
D/D |
(22,500) |
111,700 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
23,166 |
358,261 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2009-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
356,000 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-12-28 |
4 |
A |
$3.66 |
$94,845 |
D/D |
25,914 |
2,397,255 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2008-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
257,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-01-19 |
4 |
AS |
$151.92 |
$4,318,902 |
D/D |
(28,099) |
134,200 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-01-10 |
4 |
OE |
$16.14 |
$545,371 |
D/D |
33,790 |
119,209 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
39,517 |
2,462,686 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-01-27 |
4 |
AS |
$182.00 |
$7,280,000 |
D/D |
(40,000) |
243,422 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,922 |
424,731 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-13 |
4 |
OE |
$9.96 |
$479,325 |
D/D |
48,125 |
201,739 |
0 |
- |
|
165 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
